Bioleaders Corporation Cash Flow Quality Index
Bioleaders Corporation cash flow quality index. Bioleaders Corporation (142760) has a Cash Flow Quality Index of 21.06x as of June 2024. Operating cash flow of ₩19.27 Billion exceeds net income of ₩914.71 Million, indicating high earnings quality where cash backs reported profits. See Bioleaders Corporation free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Bioleaders Corporation (2023–2023)
Cash flow quality index of Bioleaders Corporation from 2023 to 2023. Historical Cash Flow Quality Index for Bioleaders Corporation across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Bioleaders Corporation debt service capacity to assess how comfortably operating cash covers total debt obligations.
Bioleaders Corporation Cash Flow Quality Index by Year (2023–2023)
Bioleaders Corporation cash flow quality index by year from 2023 to 2023. Year-by-year earnings quality comparison for Bioleaders Corporation. For the full cash flow conversion analysis, see 142760 operating cash flow.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.76x | ₩6.18 Billion | ₩8.07 Billion | — |